zoladex
astrazeneca (israel) ltd - goserelin as acetate - implant - goserelin as acetate 3.6 mg/unit - goserelin - goserelin - treatment of prostate cancer suitable for hormonal manipulation. breast cancer in pre-menopausal women suitable for hormone manipulation.endometriosis. assisted reproduction: pituitary down regulation in preparion for superovulation. endometrial thinning: zoladex is indicated for the prethinning of the utetine endometrium prior ro endometrial ablation or resection. uterine fibroids: for reduction of fibroid size prior to surgery.
zoladex 3.6 milligram implant
b & s healthcare - goserelin acetate - implant - 3.6 milligram - gonadotropin releasing hormone analogues
zoladex 3.6mg implant safesystem pre-filled syringes
astrazeneca uk ltd - goserelin acetate - prolonged-release subcutaneous implant - 3.6mg
zoladex la 10.8 mg implant
astrazeneca ab - goserelin - implant - 10.8 milligram(s) - gonadotropin releasing hormone analogues; goserelin
zoladex 3.6 mg implant s.c. pre-filled syr.
astrazeneca sa-nv - goserelin acetate - eq. goserelin 3,6 mg - implant - 3,6 mg - goserelin acetate - goserelin
zoladex 3,6 mg implant
pi pharma - goserelin acetate - implant - 3,6 mg - goserelin acetate - goserelin
zoladex long acting 10.8 mg implant s.c. pre-filled syr.
astrazeneca sa-nv - goserelin acetate - eq. goserelin 10,8 mg - implant - 10,8 mg - goserelin acetate - goserelin
zoladex long acting 10,8 mg implant
pi pharma - goserelin acetate - implant - 10,8 mg - goserelin acetate - goserelin
zoladex 3,6 mg implant
orifarm - goserelin acetate - implant - 3,6 mg - goserelin acetate - goserelin
zoladex 3.6 mg depot implant in pre-filled syringe
astrazeneca uk ltd parklands alderley park macclesfield cheshire - goserelin acetate - implant in pre-filled syringe - 3.6 mg goserelin acetate per depot - hormones and related agents: